Haoxi Health Technology Signs Strategic Cooperation to Develop AI Digital Marketing System

Haoxi Health Technology (NASDAQ:HAO) has signed a strategic cooperation framework agreement with NOVA MEDIA to develop an AI digital marketing system aimed at automating content creation and enhancing digital marketing capabilities for healthcare advertisers.

Key Investor Takeaways

• Haoxi Health Technology (NASDAQ:HAO) signed a strategic cooperation framework with NOVA MEDIA to develop an AI digital marketing system.
• The planned platform will combine AI digital human technology, generative AI, and workflow automation to support marketing operations.
• The collaboration is designed to automate content production and improve intelligent decision-making across digital campaigns.
• The initiative targets healthcare marketing on major Chinese platforms, including Toutiao, Douyin, WeChat, and Sina Weibo.
• The agreement supports HAO’s strategy to expand its portfolio of AI-enabled marketing services.

Why HAO Stock Is in Focus

Haoxi Health Technology announced a strategic cooperation framework agreement with NOVA MEDIA to jointly develop an AI-powered digital marketing platform.

According to the company, the planned system will integrate AI digital humans, automated content generation, and end-to-end workflow automation into a unified platform supporting healthcare marketing campaigns.

The companies intend to combine NOVA MEDIA’s expertise in generative AI with Haoxi’s experience in digital marketing for the health and wellness sector. The system is expected to streamline creative content production while supporting marketing campaigns across leading Chinese digital platforms, including Toutiao, Douyin, WeChat, and Sina Weibo.

Why This Matters for Investors

The agreement reflects Haoxi’s effort to incorporate artificial intelligence into its core digital marketing business.

If successfully developed, the AI digital marketing system may improve content production efficiency and strengthen the company’s service offering for healthcare advertisers. The initiative could also support broader adoption of AI-driven marketing tools within Haoxi’s existing client base.

However, the announcement is a strategic cooperation framework rather than a commercial contract. The company did not disclose financial terms, development timelines, or expected revenue contributions, leaving the commercial impact dependent on future execution.

What to Watch Next

Investors will likely monitor:

• Development progress for the AI digital marketing system.
• Additional details on commercialization and deployment timelines.
• Customer adoption of AI-enabled marketing services.
• Future partnerships or commercial agreements stemming from the collaboration.
• Updates on how AI tools contribute to Haoxi’s digital marketing business.

Haoxi Health Technology stock price